The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01C | Beta-lactam antibacterials, penicillins | |
| 4 | J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors | |
| 5 | J01CR02 | Amoxicillin and enzyme inhibitor |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 1 g |
| PAREN - Parenteral | 3 g |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ACTIMENTIN Powder for oral suspension | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| AUGMENTIN Powder for suspension / Film coated-tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| CLAVOMID 250 mg/125 mg Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| CLAVOMID 500 mg/125 mg Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| CURAM Powder for oral suspension / Film-coated tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| SYNTOCLAV Film-coated tablet, Powder for oral suspension | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| SYNTOCLAV Powder for solution for injection or infusion | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
